| CAA | Cerebral amyloid angiopathy |
| CNS | Central nervous system |
| ICH | Intracerebral haemorrhage |
| Aβ | Amyloid beta protein |
| APP | Amyloid precursor protein |
| TFNEs | Transient focal neurological events |
| AD | Alzheimer’s disease |
| DW-MRI | Diffusion weighted magnetic resonance imaging |
| PET | Positron emission tomography |
| CSF | Cerebrospinal fluid |
| SMCs | Smooth muscle cells |
| BBB | Blood-brain barrier |
| LRP-1 | Low density lipoprotein receptor-related protein 1 |
| RAGE | Receptor advanced glycation end products |
| BCRP | Breast cancer resistance protein |
| P-gp | Permeability glycoprotein |
| MMPs | Matrix metallopeptidases |
| apoE | Apolipoprotein E |
| HCHWA-D | Hereditary cerebral haemorrhage with amyloidosis-Dutch type |
| NVU | Neurovascular unit |
| VSMCs | Vascular smooth muscle cells |
| CBF | Cerebral blood flow |
| ROS | Reactive oxygen species |
| HDL | High-density lipoprotein |
| BCAS | Bilateral common carotid artery stenosis |